Preve
PrivateLast Round
Seed
May 23, 2025
Total Funding Raised
$1.71M
Company Overview
Preve operates in Healthcare & Life Sciences and is based in Brisbane. Its latest recorded funding round was a Seed round in May 2025.
Preve is an AI-powered clinical assistant and patient engagement platform that provides automated clinical documentation, treatment planning, and rehabilitation programs for physiotherapists.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Medical AI, Patient Engagement, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preve Comparables
Compare Preve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Claire Health LLC | 88% | |
| AllyScribe | 85% | |
| CliniScribe | 84% |
For institutional investors. Book with your work email.
Preve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 23, 2025 | ||||
| Pre Seed | Jul 1, 2024 |
For institutional investors. Book with your work email.
Preve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startmate | Seed, Pre Seed |
| Carthona Capital | Seed |
| Black Sheep Capital | Seed |
| Archangel | Seed, Pre Seed |
| Exhort Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 40% MoM, reaching 32.8K.
- Jul 14, 2025
Grew 20% QoQ from 15 to 18 employees.
For institutional investors. Book with your work email.
Preve Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Preve's valuation, stock price, and market status.
Is Preve a public or private company?
Preve is a private company.
What is the current stock price of Preve?
Preve is a private company, so its shares have no public market price. Caplight tracks Preve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Preve worth (valuation)?
Valuation information for Preve is not publicly available.
Can I buy Preve stock?
Preve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Preve's last funding round?
Preve's most recent funding round was Seed on May 23, 2025.
Who are the main investors in Preve?
Key investors in Preve include Carthona Capital.
Will Preve IPO soon?
No public IPO plans have been announced for Preve.
How can I track Preve secondary market activity?
Caplight tracks bids, offers, and trades in Preve's shares on secondary markets.